Torrent Pharmaceuticals Limited — PPTs, 25-10-2024: Investor Presentation

Torrent Pharmaceuticals Limited reported its unaudited consolidated financial results for Q2 FY 2024-25, revealing a 9% increase in total revenues to ₹2,889 crore compared to ₹2,660 crore in Q2 FY 2023-24. Notable growth was observed in India (+13%) and Germany (+8%), while revenues from the U.S. declined by 3%. For H1 FY 2024-25, total revenues rose by 9% year-on-year, reaching ₹5,748 crore.